Coordinating sites

MRC Clinical Trials Unit at UCL

The MRC CTU at UCL is world leading in designing and conducting innovative and challenging clinical trials in cancer and infectious diseases as well as conducting meta-analyses and systematic reviews. As well as providing funding for the ARCHERY trial, our team at the MRC CTU will oversee the everyday coordination of the trial. Visit the MRC CTU website to find out more about the unit's work.

(L-R Chiara Borg, Carol Roach, Claire Murphy, Ajay Aggarwal, Isabella Jacques, Matthew Nankivell, Lee Barker)

The ARCHERY team at the MRC CTU includes:

Carol Roach - Trial Manager

Claire Murphy - Clinical Project Manager

Ajay Aggarwal - Chief Investigator

Isabella Jacques - Data Manager

Matthew Nankivell - Senior Statistician 

Lee Barker - Database Programmer/Systems Analyst

Chiara Borg (former team member) - Clinical Project Manager for Data Management

MD Anderson Cancer Centre

The University of Texas' MD Anderson Cancer Centre conducts one of the world's largest clinical trials programs, offering thousands of clinical trials covering prevention, diagnosis, treatment and survivorship of cancer. The Court Lab at MD Anderson will be responsible for applying the AI radiotherapy planning to patient CT scans. Visit the Court Lab website to find out more about their research.

The ARCHERY team at MD Anderson includes:

Laurence Court - Associate Professor

Lifei Joy Zhang - Manager in Scientific Computing Research

Tucker Netherton - Assistant Professor

Callistus Nguyen - Computational Scientist

Raphael Douglas - Senior Research Assistant in Radiation Physics 

The Radiotherapy Trials Quality Assurance (RTTQA) Group

The Radiotherapy Trials Quality Assurance (RTTQA) Group is an independent, multidisciplinary network, based across a number of UK NHS sites, with the remit to monitor safety, consistency and accuracy of treatment within clinical trials. Within ARCHERY, the RTTQA group team at the Mount Vernon Cancer Centre will provide an assessment of the AI radiotherapy treatment plans as to whether they can be considered clinically acceptable.

The ARCHERY team at the RTTQA at Mount Vernon Cancer Centre includes:

Elizabeth Miles - RTTQA Group Lead

Mariana Kroiss - Senior Radiotherapy Physicist

Peter Hoskin - Professor of Clinical Oncology

Ghent University

To quantify the cost and resource savings of using the RPA compared to the manual approach, the approved time-driven activity-based costing model developed by the European Society for Radiotherapy and Oncology (ESTRO) Health Economics in Radiation Oncology (HERO) project will be used. The HERO project is co-chaired by Yolande Lievens at Ghent University. Time-and-motion studies will be undertaken to populate the costing model. Visit the HERO page on the ESTRO website to find out more about the project.

The ARCHERY team at Ghent University includes:

Yolande Lievens - Chair of ESTRO and Co-Chair of HERO

Barbara Vanderstraeten - Radiation Physicist